Vaccine Market Studied in Detail by Focusing on Product Type, Test Type, Application, And Competitive Landscape with Top Companies
The global
vaccine market is growing significantly due increasing initiatives by
non-government organizations to provide immunization and improvement in
production technique of vaccine in the industry. Various programs and campaigns
are organized, such as Immunization Week by World Health Organization, to
create awareness among the population all over the world. Massive unexplored
market in vaccine industry of developing economies are creating ample
opportunities for the vaccine market to grow at a considerable rate in the
coming years.
Moreover, the advanced research and development facilities,
and new and innovative product developments by the companies are propelling the
growth of the vaccine industry. Increasing prevalence of cancer and infectious
diseases is fuelling the growth of the vaccine market. Infectious diseases are
the major contributor to the human mortality and morbidity. According to World
Health Organization, approximately 129,064 cases were reported in 2013.
Vaccination has rescued millions of lives to provide secure and better life.
Request to Get the Sample Pages at:
Some of the factors driving the growth of global vaccine
market are rising government and non-government funding for vaccine
development, increasing prevalence of diseases such as cancer and infectious
diseases, and increasing use of adjuvants in vaccine preventable diseases. In
addition, increasing healthcare expenditure, and increasing awareness about
immunization are also some of the factors fueling the growth of the global
vaccine market. However, strict regulatory requirements for approval of drugs
and high capital investment in research and development are some of the factors
restraining the growth of the vaccine market to some extent.
Geographically, North America will be leading the global vaccine
market in the coming years, due to increasing government funding for vaccines,
increasing company investments for vaccine research and increasing prevalence
of diseases. Asia-Pacific is the fastest growing region in the global vaccine
market. The major reasons for the fastest growth of vaccine market in the
region are improving healthcare infrastructure, increasing healthcare
expenditure, large population base suffering from various diseases, in the
region. Moreover, the vaccine market is growing due to increasing immunization
initiatives and awareness by organizations, such as World Health Organization
and GAVI, in the emerging countries, such as India and China, of Asia-Pacific
region.
Some of the companies operating in the global vaccine market
are GlaxoSmithKline, Plc., CSL Limited, Sanofi, Medimmune, LLC., Emetgent
Biosolutions, Inc., Novartis, AG, Pfizer, Inc., Merck & Co., Inc., Bavarian
Nordic, and Johnson & Johnson.
Comments
Post a Comment